📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Laxmi Dental Q3 Revenue Up 7.1% YoY to ₹660 Mn; PAT Drops 59% on Exceptional Item
Laxmi Dental reported a 7.1% YoY revenue growth in Q3FY26, reaching ₹660.4 million, driven by strong international lab business growth of 25.5%. However, PAT declined significantly by 59.3% YoY to ₹19.6 million, primarily due to a one-time exceptional provision of ₹57.8 million for gratuity liabilities under new labour codes. EBITDA margins compressed to 10.6% from 15.6% a year ago, impacted by higher US tariffs (150 bps) and ESOP expenses. Management remains optimistic about Q4 recovery in the domestic market and normalization of pricing pressures in the aligner segment.
Key Highlights
Revenue grew 7.1% YoY to ₹660.4 Mn in Q3FY26; 9M FY26 revenue up 14.3% to ₹2,039 Mn.
PAT fell 59.3% YoY to ₹19.6 Mn, impacted by a ₹57.8 Mn exceptional item for labour code compliance.
International dental lab business showed robust growth of 25.5% YoY, offsetting soft domestic performance.
EBITDA margins stood at 10.6%, affected by 150 bps impact from US tariffs and ₹16.14 Mn ESOP expenses.
Gross profit margins remained steady at 69.5% with sequential improvement due to lower low-margin scanner sales.
💼 Action for Investors
Investors should monitor the recovery in domestic lab and aligner segments in Q4, as management indicates positive trends starting January 2026. While one-time costs hit the bottom line, the strong international growth and strategic positioning in digital dentistry remain key long-term drivers.
Laxmi Dental Q3FY26 Revenue Up 7% to ₹660 Mn; PAT Impacted by ₹57.8 Mn Exceptional Item
Laxmi Dental reported a 7.1% YoY revenue growth to ₹660.4 Mn for Q3FY26, supported by a robust 25.5% growth in its international dental lab business. However, net profit fell 59.3% YoY to ₹19.6 Mn, primarily dragged down by a one-time exceptional provision of ₹57.8 Mn for gratuity liabilities under the new labour code. EBITDA margins were also pressured by higher US tariffs (150 bps impact) and increased ESOP expenses. Despite these headwinds, the company saw a ₹32.2 Mn deferred tax credit from its US subsidiary and expects a stronger Q4 recovery.
Key Highlights
Consolidated Revenue grew 7.1% YoY to ₹660.4 Mn in Q3FY26, with 9M FY26 revenue up 14.3% to ₹2,039 Mn.
International lab business delivered 25.5% YoY growth, while domestic lab business remained soft during the quarter.
EBITDA margin contracted to 10.6% from 15.6% YoY due to ₹16.1 Mn ESOP costs and global macroeconomic challenges.
A one-time exceptional provision of ₹57.8 Mn was recorded for gratuity past service liability under the new labour code.
Scanner sales grew 46% YoY in Q3, acting as a strategic lead generator for the higher-margin lab and aligner segments.
💼 Action for Investors
Investors should focus on the normalization of US tariffs and the management's guidance for a robust Q4 recovery in domestic segments. While one-time provisions hurt the bottom line, the strong growth in international markets and digital dentistry (scanners) remains a positive long-term indicator.
Laxmi Dental Reports Q3 FY26 Revenue of ₹477.7M; Net Loss of ₹18.9M on Exceptional Labour Code Costs
Laxmi Dental reported a year-on-year revenue growth of 11.7% for Q3 FY26, reaching ₹477.74 million. However, the company swung to a net loss of ₹18.90 million for the quarter, compared to a profit of ₹32.14 million in the same period last year. This loss was primarily driven by a one-time exceptional item of ₹51.56 million related to gratuity provisions under the New Labour Codes. For the nine-month period, net profit stands at ₹125.40 million, a significant decline from ₹215.99 million in the previous year.
Key Highlights
Revenue from operations grew 11.7% Y-o-Y to ₹477.74 million, though it declined 11.1% on a Q-o-Q basis.
Reported a Net Loss of ₹18.90 million in Q3 FY26 vs a Net Profit of ₹32.14 million in Q3 FY25.
Recognized a one-time exceptional expense of ₹51.56 million for incremental gratuity impact following New Labour Code notifications.
Employee benefit expenses increased by 30% Y-o-Y to ₹200.91 million.
Utilized ₹669.78 million of IPO proceeds to date, with ₹611.92 million currently held in fixed deposits.
💼 Action for Investors
Investors should treat the net loss as largely non-recurring due to the one-time labour code provision, but should monitor the sequential decline in revenue. Watch for stabilization in operating margins and the deployment of remaining IPO funds for growth.